Back

Platelet reactivity in Hepatitis C virus infected patients on dual antiplatelet therapy for acute coronary syndrome

3 September 2019 (14:00 - 18:00)
Organised by:
Congress Presentation Part of: Poster Session 7 - Acute Coronary Syndromes - Treatment antiplatelet Pharmacotherapy ESC Premium Access ESC Congress 2019

About the speaker

Photo
Doctor Fernando Scudiero

Bolognini Hospital, Seriate (Italy)

9 More presentations in this session

Presentation thumbnail
Doctor A. Shimizu (Kitakyushu, JP)
Abstract
Presentation thumbnail
Doctor S. Alegria (Almada, PT)
Abstract
Presentation thumbnail
Doctor J. Ferreira (Coimbra, PT)
Abstract
Presentation thumbnail
Doctor S. Koga (Tokyo, JP)
Abstract
Presentation thumbnail
Doctor R. Modolo (Maple Grove, US)
Abstract

Access the full session

Session thumbnail
Poster Session 7 - Acute Coronary Syndromes - Treatment antiplatelet

The Event

Event poster

ESC Congress 2019

3 September 2019 14:00 CET
You may be interested in
thumbnail
Congress Presentation
Association between platelet reactivity and long-term bleeding complications following percutaneous coronary intervention in patients with and without diabetes
27 August 2021
thumbnail
Congress Presentation
Combined anticoagulant and antiplatelet therapy is associated with an improved outcome in hospitalised patients with COVID-19: a propensity matched cohort study
26 August 2022
thumbnail
Congress Presentation
Biologic significance of healed culprit plaques in stable angina versus acute coronary syndromes
31 August 2019
thumbnail
Congress Presentation
Residual platelet activity and systemic inflammation in patients with chronic coronary syndrome in the context of aspirin monotherapy.
29 June 2021

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources